PrimeInvestor - Articles and Reports

textile sector, textile sector outperformance
Premium
Pavithra Jaivant

Sector analysis: What’s changing in the textile sector?

A long-forgotten sector that has made a big comeback in the most recent leg of Indiaโ€™s bull market is the textile sector. The rally was pretty hard to miss. The stock price of KPR Mills has more than doubled from July 2021 to January 2022 while Vardhman Textiles and Welspun surged over 60%. AK Spintex, a textile stock that has flown under the radar for a while, climbed nearly 190% in just the first two weeks of the new year, leaving many baffled. One-year stock returns have been in excess of 100% for many players. Here are the absolute stock returns on a few textile stocks.

Read More

Important Update: Change in our stock recommendation

We are moving this stock from a Buy to a Hold until we receive clarity on the funding plan and capex timeline. That means, those who have already invested in the stock may continue to hold, but avoid additional investments.

Premium article available only to subscribers.

Read More
drug discovery, drug discovery outsourcing, CRO, CDMO, CRAMS
Categories
N V Chandrachoodamani

Prime Stock recommendation : A preferred partner for drug discovery outsourcing

The company we have recommended is assisting global bio-pharmaceutical companies in the end-to-end process of drug discovery to manufacturing. There is an increasing trend within the global life sciences industry to partner with integrated contract research organisations that can provide customised and end-to-end solutions to both large conglomerates to young startup biotechs.

Premium article available only to subscribers.

Read More
Interest rates, move out of equities
Categories
R Balakrishnan

Interest rates: Should you move out of equities?

Long-standing warnings by market gurus about the imminent popping of the stock market bubble seemed to come good, with interest rates for US treasuries spiking up sharply and triggering a fairly sharp correction in stock prices across the world. But why should stocks fall if interest rates rise and will such a rate hike impact India?

Read More
Prime Equity Outlook 2022
Categories
Aarati Krishnan

Prime Equity Outlook 2022

Prime Equity Outlook 2022
Itโ€™s a little difficult to be optimistic about the year ahead when news headlines and social media debates are all about Covid counts and the mysterious symptoms of Omicron (or is it Deltacron?). Indeed, as we write this, two-thirds of PrimeInvestorโ€™s tiny team has also been struck down by Covid-ish symptoms.ย 

Read More
Prime Stocks performance
Categories
PrimeInvestor Research Team

Prime Stocks performance review – 2021

It is with mixed feelings that we write this first annual review of our Prime Stocks performance. When we flagged off stock recommendations as a new addition to our platform on January 14 2021, it was after a lot of internal debate on whether it was the right time to do this.ย 

Read More
next for Nifty 50
Categories
B Krishnakumar

After the correction, whatโ€™s next for Nifty 50?

After the correction, whatโ€™s next for Nifty 50? In our previous post on the outlook for the Nifty 50 index, we had shared the view that the correction in the Nifty 50 was incomplete, and we were making a case for a bounce to a lower high and one more push lower.

Read More
Godrej Group, Split in godrej group
Categories
N V Chandrachoodamani

The planned split in the Godrej Group: What to expect

One such reputed family-owned business empire in India has been the Godrej group, founded in 1897. Starting from โ€œlockโ€ manufacturing, the company diversified into soap manufacturing in 1928 (from vegetable oils) and then to animal feeds, real estate, processed foods and chemicals.

Read More
Star Health, Star Health IPO, Star Health and Allied Insurance Co Ltd
Categories
N V Chandrachoodamani

IPO Review: Star Health and Allied Insurance Co Ltd

Star Health and Allied Insurance Co Ltd (Star Health), Indiaโ€™s leading standalone health insurer, is making an IPO worth Rs. 7,249 crore comprising a fresh issue of shares valued at Rs.2,000 crore and an offer for sale of Rs.5,249 crore. The issue will open on November 30 and close on December 2 at a price band of Rs. 870-900 per share.ย  At the upper end of the price band, Star Health will be valued at Rs. 51,800 crore (~$7 billion).

Read More
Login to your account
OR

Become a PrimeInvestor!

Get stock & mutual fund recommendations

or
Have an account?
Login To Your Account
OR
Donโ€™t have an account ? Register for free